Title:
NEW CRYSTALLINE FORM OF PIMAVANSERIN TARTRATE, PREPARATION METHOD THEREFOR, AND USE
Document Type and Number:
WIPO Patent Application WO/2018/049836
Kind Code:
A1
Abstract:
A polymorph III of N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N'-[4-(2-methylpropoxy)phenylmethyl]urea tartrate, a preparation method therefor, and a medicinal use. Compared to the existing crystalline forms, the new crystalline form has clear advantages with respect to solubility, stability and the preparation process.
Inventors:
MENG XIAOMING (CN)
Application Number:
PCT/CN2017/084983
Publication Date:
March 22, 2018
Filing Date:
May 19, 2017
Export Citation:
Assignee:
SHANGHAI BEGREAT PHARMATECH (CN)
International Classes:
C07D211/58; A61K31/4468; A61P25/16; C07C51/43; C07C59/255
Domestic Patent References:
| WO2008144326A2 | 2008-11-27 | |||
| WO2006036874A1 | 2006-04-06 |
Foreign References:
| CN104961671A | 2015-10-07 | |||
| CN105523993A | 2016-04-27 | |||
| CN104961672A | 2015-10-07 |
Download PDF:
Previous Patent: INFORMATION PROCESSING METHOD AND DEVICE
Next Patent: METHOD AND DEVICE FOR SAVING INFORMATION, TERMINAL, AND STORAGE MEDIUM
Next Patent: METHOD AND DEVICE FOR SAVING INFORMATION, TERMINAL, AND STORAGE MEDIUM